These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37120337)

  • 21. Fractures and mortality in relation to different osteoporosis treatments.
    Yun H; Delzell E; Saag KG; Kilgore ML; Morrisey MA; Muntner P; Matthews R; Guo L; Wright N; Smith W; Colón-Emeric C; O'Connor CM; Lyles KW; Curtis JR
    Clin Exp Rheumatol; 2015; 33(3):302-9. PubMed ID: 25068266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Viswanathan M; Reddy S; Berkman N; Cullen K; Middleton JC; Nicholson WK; Kahwati LC
    JAMA; 2018 Jun; 319(24):2532-2551. PubMed ID: 29946734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
    Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W
    Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05.
    Hagino H; Sugimoto T; Tanaka S; Sasaki K; Sone T; Nakamura T; Soen S; Mori S
    Osteoporos Int; 2021 Nov; 32(11):2301-2311. PubMed ID: 34002252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis.
    Nayak S; Greenspan SL
    J Am Geriatr Soc; 2017 Mar; 65(3):490-495. PubMed ID: 28304090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world effectiveness of osteoporosis treatments in Germany.
    O'Kelly J; Bartsch R; Kossack N; Borchert J; Pignot M; Hadji P
    Arch Osteoporos; 2022 Aug; 17(1):119. PubMed ID: 36044096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visualisation of the unmet treatment need of osteoporotic fracture in Taiwan: A nationwide cohort study.
    Wang CY; Fu SH; Huang CC; Hung CC; Yang RS; Hsiao FY
    Int J Clin Pract; 2018 Oct; 72(10):e13246. PubMed ID: 30144247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures.
    Lehmann T; Aeberli D
    Osteoporos Int; 2017 Oct; 28(10):3067-3068. PubMed ID: 28589418
    [No Abstract]   [Full Text] [Related]  

  • 29. CLINICAL EVALUATION OF COST EFFICACY OF DRUGS FOR TREATMENT OF OSTEOPOROSIS: A META-ANALYSIS.
    Albert SG; Reddy S
    Endocr Pract; 2017 Jul; 23(7):841-856. PubMed ID: 28448754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study.
    Lih A; Nandapalan H; Kim M; Yap C; Lee P; Ganda K; Seibel MJ
    Osteoporos Int; 2011 Mar; 22(3):849-58. PubMed ID: 21107534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study.
    González-Quevedo D; Pérez-Del-Río V; Moriel-Garceso D; Fernández-Arroyabe N; García-Meléndez G; Montañez-Ruiz M; Bravo-Bardají M; García-de-Quevedo D; Tamimi I
    Osteoporos Int; 2022 Aug; 33(8):1695-1702. PubMed ID: 35357521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: A nationwide population study.
    Tai TW; Li CC; Huang CF; Chan WP; Wu CH
    Bone; 2022 Jan; 154():116216. PubMed ID: 34571203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous Vertebroplasty Combined with Zoledronic Acid in Treatment and Prevention of Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis of Comparative Studies.
    Tang B; Zeng H; Hu S; Liu K; Wu L; Shi X
    World Neurosurg; 2022 Jan; 157():75-87. PubMed ID: 34655820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-osteoporosis drugs reduce mortality in cancer patients: A national cohort study of elderly with vertebral fractures.
    Huang CF; Kuo TT; Hsu JC; Kosik RO; Chan WP
    Ann Acad Med Singap; 2024 Jan; 53(1):6-14. PubMed ID: 38920210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
    Osteoporos Int; 2016 Jun; 27(6):1989-98. PubMed ID: 26782683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Osteoporos Int; 2011 Aug; 22(8):2347-55. PubMed ID: 21287148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review.
    Anagnostis P; Paschou SA; Gkekas NN; Artzouchaltzi AM; Christou K; Stogiannou D; Vryonidou A; Potoupnis M; Goulis DG
    Endocrine; 2018 Jun; 60(3):373-383. PubMed ID: 29411304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy and safety of drug interventions for primary and secondary prevention of osteoporotic fractures in postmenopausal women: Network meta-analysis followed by factor and cluster analysis.
    Wen F; Du H; Ding L; Hu J; Huang Z; Huang H; Li K; Mo Y; Kuang A
    PLoS One; 2020; 15(6):e0234123. PubMed ID: 32492050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Zhou J; Ma X; Wang T; Zhai S
    Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.